Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast

Forecasting

Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

News

7/27/2020 Pharmaceutical Drug Import to Russia (June and First Half of 2020)

Between January and June 2020, Russia imported 269.3 bln RUB worth of ready-made pharmaceuticals (customs clearance and VAT included), which is in monetary terms (rubles) 2% lower than in 2019. The dynamics were even lower in May 2020 (-27%), but in June, the importers sought to have their stocks replenished after it became clear that the launch of the labeling system would not be postponed again. As for in-bulk pharmaceutical drugs, the import volume amounted to 64.5 bln RUB, with the dynamics of +20%.

7/27/2020 API Import to Russia (June and First Half of 2020)

Between January and June 2020, Russia imported 87.3 bln RUB worth of APIs (customs clearance and VAT included), which is in monetary terms (rubles) 54% higher than in 2019. In physical terms, the import volume amounted to 7.3 thousand tons of APIs, including commercial ones, with the dynamics of +25%.

7/23/2020 Database Update: Veterinary Drug Retail Sales Audit in Russia (June 2020)

Between January and June 2020, the sales of veterinary drugs in the retail market amounted to 10.7 bln RUB (retail prices, VAT included), with the dynamics in monetary terms (rubles) of +1.3%. In physical terms (minimum dosage units), the market volume is 92.2 mln MDUs, with the dynamics of +1.1%.

7/9/2020 Survey by RNC Pharma and Doktor Na Rabote (Doctor at Work): 59% of Russian Doctors Consider Telemedicine Possible

More than a third (35%) of doctors are adamantly opposed to the idea of telemedicine, according to a survey by the RNC Pharma analyst company and the Doktor Na Rabote (Doctor at Work) social media service for doctors.

7/6/2020 Import of Veterinary Drugs and Feed Supplements to Russia (May 2020)

Between January and May 2020, Russia imported 11.3 bln RUB worth of veterinary drugs (customs clearance and VAT included), which is in monetary terms (rubles) 2.3% lower than in 2019, and 16.9 bln RUB worth of feed supplements, with the dynamics of +12.9% in monetary terms.

6/30/2020 API Import to Russia (May 2020)

Between January and May 2020, Russia imported 69.7 bln RUB worth of APIs (customs clearance and VAT included), which is in monetary terms (rubles) 51% higher than in 2019. The dynamics in physical terms (kilograms) are +21%, with the import volume of 5.8 thousand tons.

6/29/2020 Pharmaceutical Drug Import to Russia (May 2020)

Between January and May 2020, Russia imported 168.6 bln RUB worth of ready-made pharmaceuticals (customs clearance and VAT included), which is in monetary terms (rubles) 27% lower than in 2019, and 52.5 bln RUB worth of in-bulk drugs, which is 12% higher than in 2019.

6/25/2020 Database Update: Veterinary Drug Retail Sales Audit in Russia (May 2020)

Between January and May 2020, the sales of veterinary drugs in the retail market amounted to 8.9 bln RUB (retail prices, VAT included). While the dynamics in monetary terms (rubles) are only +0.9%, sales got back to normal in May after April’s devastating results (the dynamics for the period between January and April were +0.6%). If calculated in minimum dosage units (MDU), the market volume is 82.4 mln MDUs, with the dynamics of +3.4%.

6/24/2020 Survey by RNC Pharma and Doktor Na Rabote (Doctor at Work): 53% of Russian Doctors Do not Think that the COVID-19 Epidemic in Russia Has Ended Yet

53% of doctors believe that the coronavirus epidemic in Russia has not yet ended, according to a survey by the RNC Pharma analyst company and the Doktor Na Rabote (Doctor at Work) social media service for doctors. That is why it is too early to make predictions about the beginning of the so-called “second wave” of the disease. Here, we can also see some serious gender differences; 59% of the female and only in 35% the male respondents do not think the epidemic has ended.

6/23/2020 Pharmaceutical Drug Production in Russia (May 2020)

Between January and May 2020, Russia manufactured 189.1 bln RUB worth of pharmaceutical drugs (manufacturers’ dispatch prices, VAT included), which is in monetary terms (rubles) 20% higher than in 2019. The dynamics in physical terms (units) are +8.2% (1.88 bln units). If calculated in minimum dosage units (MDU), the dynamics are +11.7% (33.2 bln MDUs).